Cidara Therapeutics Inc.

NASDAQ: CDTX · Real-Time Price · USD
65.38
1.83 (2.88%)
At close: Aug 15, 2025, 3:59 PM
66.00
0.95%
After-hours: Aug 15, 2025, 04:56 PM EDT

Cidara Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
189.82M 35.78M 32.73M 62.27M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
96K 1.05M 634K 533K
Receivables
1.69M 16.25M 5.83M 5.36M
Inventory
n/a 6.1M n/a -2.59M
Other Current Assets
19.22M 2.73M n/a 2.59M
Total Current Assets
210.74M 60.85M 45.09M 71.7M
Property-Plant & Equipment
3.96M 5.13M 1.43M 2.54M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
4.06M 6.17M 2.5M 3.63M
Total Assets
214.8M 67.03M 47.59M 75.33M
Account Payables
3.61M 3.77M 1.45M 1.3M
Deferred Revenue
n/a 25.09M 14.61M 13.92M
Short-Term Debt
1.64M n/a 1.21M 2.59M
Other Current Liabilities
42.66M 32.22M -1.21M 10.2M
Total Current Liabilities
49.55M 67.42M 41.4M 34.02M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
1.93M 7.82M 20.52M 19.73M
Total Liabilities
51.49M 75.24M 50.5M 53.75M
Total Debt
3.58M 4.88M 1.21M 5.06M
Common Stock
1K 9K 7K 7K
Retained Earnings
-611.26M -441.43M -406.97M -377.17M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
163.31M -8.21M -2.9M 21.57M
Total Investments
n/a n/a n/a n/a